Monoclonal Antibody Therapy for COVID-19: A Retrospective Observational Study at a Regional Hospital.

Judith PannierNorbert NassMohamad-Kamal YaakoubFlorian Michael Maria StelznerSusann VeitMargarita KalomoiriMahdi YassineGerhard Behre

Published in: Infectious disease reports (2023)

Apparently, the application of anti-SARS-CoV-2 antibodies reduced the work load of our hospital as shown by the shorter hospitalization time and lower number of COVID-19-related deaths.

Keyphrases

sars cov
monoclonal antibody
coronavirus disease
respiratory syndrome coronavirus
healthcare
acute care
adverse drug
drug induced